Physical Activity Cuts Mortality in Colorectal Cancer Survivors

This article originally appeared here.
Share this content:
Physical Activity Cuts Mortality in Colorectal Cancer Survivors
Physical Activity Cuts Mortality in Colorectal Cancer Survivors

(HealthDay News) -- For patients with invasive, non-metastatic colorectal cancer, increased recreational physical activity is associated with reduced all-cause mortality, while prolonged sedentary time correlates with increased all-cause mortality, according to a study published online Jan. 22 in the Journal of Clinical Oncology.

Peter T. Campbell, Ph.D., from the American Cancer Society National Home Office in Atlanta, and colleagues examined the correlation of pre-diagnosis and post-diagnosis recreational physical activity and sedentary leisure time with mortality among 2,293 adults diagnosed with invasive, non-metastatic colorectal cancer from a cohort of adults without colorectal cancer at baseline.

During a maximum follow-up of 16.1 years after colorectal cancer diagnosis, the researchers found that 846 patients died -- 379 from colorectal cancer. Significantly lower all-cause mortality was seen for those who engaged in 8.75 or more metabolic equivalent (MET) hours per week of recreational activity versus less than 3.5 MET hours (relative risks for pre-diagnosis and post-diagnosis physical activity, 0.72 and 0.58, respectively). Higher all-cause mortality was seen for those who spent six or more hours per day of leisure time sitting compared with fewer than three hours per day (relative risks for pre-diagnosis and post-diagnosis sitting time, 1.36 and 1.27, respectively).

"In conclusion, this study supports public health recommendations for recreational physical activity and the avoidance of sedentary time among colorectal cancer survivors," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs